Saturday, August 20, 2011

Melanoma Drug Approved by FDA

But it won't work for Meagan. It targets a genetic mutation she does not have. It does illustrate the direction cancer drug research is heading - moving from slash, burn and poison to smarter targeting of individual mutations.

http://www.webmd.com/melanoma-skin-cancer/news/20110817/zelboraf-approved-for-late-stage-melanoma

No comments:

Post a Comment